V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280009315 | 280009416 | 1.8 | 83 | null | 2017-08-10 | 2017-08-15 | EVEROLIMUS | N | N | 280030702 | ETOPOSIDE |
| 280009316 | 280006570 | 1.71 | 98 | Palliative (P) | 2017-05-12 | 2017-05-12 | Etoposide IV | null | null | 280030705 | VINCRISTINE |
| 280009317 | 280006576 | 1.69 | 86 | Palliative (P) | 2013-08-19 | 2013-08-19 | CISPLATIN + FLUOROURACIL + RT | N | N | 280030707 | ETOPOSIDE |
| 280009318 | 280006577 | 1.73 | 96 | Curative (C) | 2015-05-02 | 2015-05-30 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280030712 | IDELALISIB |
| 280009319 | 280006579 | 1.61 | 67.4 | Palliative (P) | 2015-10-24 | 2015-10-31 | VIDE | N | N | 280030712 | VIDE |
| 280009320 | 280006580 | 1.73 | null | Palliative (P) | 2015-08-23 | 2016-05-24 | GEMCITABINE + NAB PACLITAXEL | N | N | 280030717 | TEMSIROLIMUS |
| 280009321 | 280006580 | null | 52 | Curative (C) | 2016-07-10 | 2016-07-10 | Hydroxycarbamide | N | N | 280030717 | CARBOPLATIN + CETUXIMAB + FU |
| 280009322 | 280006581 | null | 92.9 | Palliative (P) | 2013-11-16 | 2013-11-18 | DACTINOMYCIN + CYCLO + VINCRISTINE | 02 | N | 280030724 | PEMBROLIZUMAB |
| 280009323 | 280006584 | 1.59 | 88 | Palliative (P) | 2018-01-11 | 2018-01-24 | Cyclophosphamide + Topotecan | 02 | N | 280030724 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 280009324 | 280006584 | 1.71 | null | Curative (C) | null | 2016-10-21 | BLEOMYCIN + CISPLATIN + VINCRISTINE | null | null | 280030724 | RITUXIMAB |
| 280009325 | 280006586 | 1.63 | 94 | Palliative (P) | 2015-02-04 | 2015-07-02 | Eribulin | N | N | 280030729 | CREATE TRIAL |
| 280009326 | 280006587 | null | 36.7 | Adjuvant (A) | 2015-02-20 | 2015-04-08 | CARBOPLATIN + FLUOROURACIL | null | null | 280030732 | IVADO |
| 280009327 | 280009423 | 1.8 | 58.2 | Palliative (P) | 2016-12-27 | 2016-12-27 | CARBOPLATIN + FLUOROURACIL | N | N | 280030733 | CARBO + FLUOROURACIL |
| 280009328 | 280006588 | 1.62 | 72.5 | Curative (C) | 2015-06-12 | 2015-06-20 | Trastuzumab 21 day maintenance | 02 | N | 280030739 | IVADO |
| 280009329 | 280006589 | 0 | 92 | Curative (C) | 2019-02-06 | 2019-02-22 | IVADo | N | N | 280030742 | CISPLATIN + FLUOROURACIL + RT |
| 280009330 | 280006589 | 1.84 | 0 | Palliative (P) | null | 2016-12-27 | EOX | null | null | 280030742 | IRINOTECAN + VINCRISTINE |
| 280009331 | 280006592 | 1.59 | 98.55 | Palliative (P) | null | 2016-02-26 | NIVOLUMAB | N | N | 280030765 | PEMBROLIZUMAB |
| 280009332 | 280006592 | 1.82 | 64.2 | Palliative (P) | 2015-07-19 | 2015-07-19 | Bevacizumab 7.5mg/kg | N | N | 280030765 | CASPS TRIAL |
| 280009333 | 280006594 | 1.85 | 84.7 | Palliative (P) | 2016-09-17 | 2016-09-24 | EVEROLIMUS | Y | null | 280030774 | DACTINOMYCIN + CYCLO + VINCRISTINE |
| 280009334 | 280006596 | null | 47 | null | null | 2017-05-03 | Pazopanib | null | null | 280030774 | CISPLATIN + DOCETAXEL + FLUOROURACIL + RT |
| 280009335 | 280006597 | 1.87 | 92 | Palliative (P) | 2014-07-14 | 2014-07-20 | Trastuzumab 21 day maintenance | 2 | N | 280030783 | DARS TRIAL |
| 280009336 | 280006597 | 1.78 | 66.8 | Palliative (P) | 2015-12-18 | 2016-01-09 | Capecitabine + Oxaliplatin 21day | 2 | N | 280030783 | IVADO |
| 280009337 | 280006600 | 1.73 | 77.05 | Palliative (P) | 2015-04-15 | 2015-11-27 | Dactinomycin + Vincristine | N | N | 280030786 | CASPS TRIAL |
| 280009338 | 280006600 | 1.61 | 54 | Curative (C) | 2017-06-10 | 2017-06-27 | EOX | N | N | 280030786 | ETOPOSIDE |
| 280009339 | 280006601 | null | 0 | Palliative (P) | 2018-09-07 | 2018-09-28 | VDC | null | null | 280030791 | CISPLATIN + DOXORUBICIN |
| 280009340 | 280009433 | 1.73 | 78.5 | Palliative (P) | 2012-11-08 | 2013-10-28 | BENDAMUSTINE + RITUXIMAB | N | N | 280030791 | CAPECITABINE + CARBOPLATIN |
| 280009341 | 280006603 | null | 119 | Palliative (P) | 2015-07-08 | 2015-08-19 | Docetaxel | 2 | N | 280030798 | PAZOPANIB |
| 280009342 | 280009434 | 1.83 | 68.4 | Palliative (P) | 2016-11-14 | 2016-12-04 | Cyclophosphamide High Dose | N | null | 280030800 | CARBO + FLUOROURACIL |
| 280009343 | 280009434 | 1.76 | 28.9 | Palliative (P) | 2015-10-22 | 2015-10-22 | Epirubicin (weekly) | 02 | Y | 280030800 | CISPLATIN + PEMETREXED |
| 280009344 | 280006605 | 1.61 | 62.5 | Palliative (P) | 2015-07-30 | 2015-08-17 | FLUOROURACIL | 02 | N | 280030813 | CARBOPLATIN + CETUXIMAB + FU |
| 280009345 | 280006606 | 1.67 | 15.7 | Curative (C) | 2016-10-29 | 2016-11-21 | CISPLATIN + ETOPOSIDE | N | N | 280030815 | AVELUMAB |
| 280009346 | 280006608 | 1.67 | 55 | Neo-adjuvant (N) | 2014-03-11 | 2014-03-15 | IVADo | 02 | N | 280030816 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 280009347 | 280006610 | 1.75 | null | Palliative (P) | 2013-08-20 | 2013-08-20 | Dactinomycin + Vincristine | N | N | 280030816 | FCR |
| 280009348 | 280006611 | 1.68 | 178 | Palliative (P) | 2015-12-10 | 2015-12-11 | Docetaxel 100mg/m2 (21 day) | 01 | N | 280030823 | DOCETAXEL |
| 280009349 | 280006611 | 1.8 | 70 | Palliative (P) | 2013-09-22 | 2013-09-23 | CAPECITABINE + TEMOZOLOMIDE | 02 | N | 280030823 | IVADO |
| 280009350 | 280006611 | 1.82 | 69 | Palliative (P) | 2015-10-04 | 2015-10-05 | Carbo F | N | null | 280030823 | CREATE TRIAL |
| 280009351 | 280006611 | 1.59 | null | Palliative (P) | 2018-06-30 | 2018-06-30 | Dactinomycin + Vincristine | N | N | 280030823 | IRINOTECAN + VINCRISTINE |
| 280009352 | 280006613 | 1.55 | null | Palliative (P) | 2015-06-05 | 2015-06-05 | LANREOTIDE | 02 | N | 280030838 | DOCETAXEL |
| 280009353 | 280006613 | null | 68 | Curative (C) | 2015-05-01 | 2015-05-01 | ECX | N | N | 280030838 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE |
| 280009354 | 280006614 | 1.75 | null | Palliative (P) | 2018-03-27 | 2018-04-08 | Carboplatin + Cetux + FU (>Cycle 2) | null | null | 280005008 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280009355 | 280006615 | 1.7 | null | Adjuvant (A) | 2017-01-03 | 2017-01-06 | Hydroxycarbamide | null | null | 280009079 | DACTINOMYCIN + VINCRISTINE |
| 280009356 | 280006615 | 1.7 | 89.8 | Palliative (P) | null | 2014-04-22 | Cisplatin + Doxorubicin | N | N | 280009079 | HCX |
| 280009357 | 280006616 | 1.62 | 84.9 | Palliative (P) | 2016-06-18 | 2016-06-29 | Dactinomycin + Vincristine | 02 | N | 280013299 | CETUXIMAB + IRINOTECAN + MDG |
| 280009358 | 280006616 | 1.75 | 50.1 | Curative (C) | 2017-11-29 | 2017-12-02 | GEMCARBO | N | N | 280013299 | CARBOPLATIN + CETUXIMAB + FU |
| 280009359 | 280006617 | 1.77 | 66.4 | Palliative (P) | 2018-11-04 | 2018-11-21 | CETUXIMAB + IRINOTECAN + MDG | Y | N | 280016663 | LIPOSOMAL DOXORUBICIN |
| 280009360 | 280006619 | null | 88.7 | Curative (C) | 2017-01-11 | 2017-01-11 | Cisplatin + Fluorouracil + RT 5day | N | null | 280017961 | PACLITAXEL + TRASTUZUMAB |
| 280009361 | 280006619 | 1.72 | 78 | Palliative (P) | 2014-08-26 | 2014-10-09 | IVADo | N | N | 280017961 | CAPECITABINE + CISPLATIN |
| 280009362 | 280006624 | 1.8 | null | Curative (C) | 2014-09-03 | 2014-09-17 | FLUOROURACIL + MITOMYCIN + RT | 1 | null | 280018104 | VIDE |
| 280009363 | 280009446 | 1.71 | 90.2 | Palliative (P) | 2015-04-11 | 2015-04-12 | Capecitabine (21days) + Carboplatin | null | null | 280018104 | VINCRISTINE |
| 280009364 | 280011472 | 1.58 | -1 | Palliative (P) | 2017-01-13 | 2017-01-24 | CISPLATIN + FLUOROURACIL + RT | N | N | 280018423 | CARBOPLATIN + LIPOSOMAL DOX |